IL6R and Miyoshi myopathy: The concomitant gain of IL6R and ADAR1 resulted in MM cell proliferation through the hyper-activation of the STAT3 pathway, conferring hypersensitivity of IL6, and as a consequence, driving the over-activation of the STAT3 pathway in cells with 1q21 amp [34].